March 2, 2021
Q1 2021
Summary and Key Findings:
  • Reporting period: November 2020 to February 2021
  • All “heroin” samples contained fentanyl cut with xylazine
  • Counterfeit or disguised pills and tablets contained various unexpected synthetic drugs (e.g., NPS)
  • para-Fluorofentanyl is increasing among the drug supply
DOWNLOAD THE REPORT